Wednesday, 30 November 2016

New Research Explores on US AV Fistula Needles Market 2017 - MedCore

US Market Report for AV Fistula Needles 2017 - MedCore is a new market research publication announced by Reportstack. General Report Contents
• Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
• Market Drivers & Limiters for each chapter segment
• Competitive Analysis for each chapter segment
• Section on recent mergers & acquisitions
The fistula first objective is to improve the quality of life and survival of hemodialysis patients through optimizing the selection of vascular access. The majority of patients will benefit most through AV fistula access. AV fistula lowers mortality rates, hospitalization and infection while minimizing costs. The push toward AV fistula and away from catheters will be a major driver of growth for the AV fistula needle market. Peritoneal dialysis does not require the use of AV fistula needles. Thus, the trend towards peritoneal dialysis will erode the number of hemodialysis patients and the amount of hemodialysis equipment sold. The market share and use of AV fistula needles are projected to decrease proportional to the number of patients transitioning from hemodialysis to peritoneal dialysis. 
An AV fistula needle enables access to the patient’s circulatory system and permits the flow of blood from the patient, to the dialyzer’s blood compartment and then back into the patient’s bloodstream. An AV fistula needle is used for patients with either an AV fistula or an AV graft; however, they are not required for patients implanted with a dialysis catheter.
Scope
2013-2023
Contact:
Debora White
Manager - Marketing
Ph: +1-888-789-6604
ReportstackMarket Research
###

No comments:

Post a Comment